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Daniel’s strain of Theiler’s virus (DA) induces a chronic demyelinating disease in the central nervous system (CNS) of
susceptible SJL mice, which serves as an excellent model of multiple sclerosis. We previously demonstrated that point
mutations near a putative virus receptor-binding site [VP1 99 (Gly to Ser) or 100 (Gly to Asp)] totally attenuate the ability of
DA to persist and induce demyelination in SJL mice. The current studies demonstrate that class II-restricted CD41 T cells
play a major role in clearing VP1 mutant DA viruses from the CNS to prevent demyelination. Infection of SJL CD4(2/2) mice
with DA-VP1-99(Ser) or DA-VP1-100(Asp) resulted in virus persistence and prominent demyelination in the spinal cord. In
contrast, infection of SJL CD8(2/2) mice with DA-VP1-99(Ser) or DA-VP1-100 did not result in virus persistence or demyeli-
nation. In addition, no virus-specific cytotoxicity was observed in CNS-infiltrating lymphocytes following infection of SJL mice
with VP1 mutant viruses. The mutant DA-VP1-99(Ser) and DA-VP1(100) viruses were in fact neurovirulent when compared to
the wild-type DA virus, as they induced an overwhelming encephalitis and early lethality (2 to 4 days postinfection) in mice
deficient in the IFN-a/b receptor. Therefore, the nondemyelinating phenotype observed with DA-VP1-99(Ser) and DA-VP1-
100(Asp) viruses is dependent in part on the CD4-mediated host immune response. © 2000 Academic Pressw
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dINTRODUCTION
The Daniel strain (DA) of Theiler’s murine encephalo-
myelitis virus (TMEV) induces chronic inflammatory de-
myelination and virus persistence in the spinal cord of
susceptible strains of mice, but is cleared from the cen-
tral nervous system (CNS) of resistant strains of mice
(Clatch et al., 1985; Rodriguez et al., 1986). The mecha-
isms by which this potentially lytic virus establishes a
ersistent infection and induces demyelination in the
NS of susceptible mice are not completely understood.
owever, the immune system has been shown to have a
ignificant role in resistance to persistent infection as
ell as to susceptibility to TMEV-induced demyelination.
MEV-induced demyelinating disease is immune-medi-
ted (Lipton and Dal Canto, 1976) and provides an ex-
ellent viral model for human multiple sclerosis.
A major goal in TMEV biology has been to identify the
olecular components of the viral genome that predis-
ose mice to viral persistence and demyelination. A
ariant of wild-type DA (wt-DA), designated as DA-P12,
1 To whom correspondence and reprint requests should be ad-
ressed at the Departments of Neurology and Immunology, Mayo
linic, 200 First St., S.W., Rochester, MN 55905. Fax: (507)-284-1637.
-mail: rodriguez.moses@mayo.edu.
2 To whom correspondence may also be addressed at the Depart-
ment of Neurology/MC2030, University of Chicago Medical Center,
5841 S. Maryland Ave., Chicago, IL 60637. Fax: (773)-702-9076. E-mail:
xlin@neurology.bsd.uchicago.edu. B
9as isolated during the 12th passage of a persistently
nfected G26-20 glioma cell line (Patick et al., 1990).
A-P12 failed to persist and induce demyelination in
usceptible SJL/J mice. Molecular sequencing of DA-P12
howed that three point mutations in VP1 [residues
9(Gly to Ser), 100(Gly to Asp), and 103(Asn to Lys)] (Lin
t al., 1998) had occurred during the G26-20 glioma cell
assage. Using wt-DA and DA-P12 recombinant and mu-
ant virus studies, we showed that mutations at VP1
esidues 99 or 100, but not at 103, were responsible for
he inability of DA-P12 to induce demyelination and per-
ist in SJL mice. Because the mutants grew less well
han wt-DA in the CNS of B63129 RAG12/2 mice deficient
in T and B cells, the change in the CNS disease pheno-
type of the mutant viruses was related in part to de-
creased neurovirulence. However, the failure to induce
demyelination and persist was not due to a general
inability of these mutant viruses to grow, since they
replicated in L-2 cells in vitro as effectively as wt-DA. We
roposed originally that a disruption of the interaction
etween the mutant DA viruses and the receptors on
ertain neural cells in vivo might have altered the ability
f the mutant viruses to demyelinate. However, the dif-
erence in CNS growth was not a complete explanation
or the failure of mutant DA-VP1-99(Ser) and DA-VP1-
00(Asp) to demyelinate, since DA-VP1-103(Lys) virus
as able to induce demyelination and persist in SJL mice
espite having a similar decrease in neurovirulence in
2/2 mice. We therefore considered that63129 RAG1
0042-6822/00 $35.00
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10 RODRIGUEZ ET AL.other mechanisms, possibly immunologic, might also be
involved in the altered phenotype observed following
infection with the mutant viruses.
The immune response is a critical factor in the control
of Theiler’s virus infection in the CNS (Rodriguez et al.,
1991). Both class I-restricted CD81 T cells and class
II-restricted CD41 T cells contribute to virus clearance
nd to resistance to virus-induced demyelination (Lin et
l., 1997, 1999; Murray et al., 1998; Nicholson et al., 1996;
jenga et al., 1996; Rivera-Quinones et al., 1998; Rodri-
uez et al., 1991). In mice of a resistant H-2b genotype,
depletion of T cell subsets with monoclonal antibodies
directed against CD41 or CD81 T cells results in an
ncreased frequency of paralysis and death due to acute
ncephalitis (Rodriguez et al., 1991). Genetic deficiency
f class II-mediated immune responses or CD41 T cells
Murray et al., 1998; Njenga et al., 1996) or deficiency of
class I-mediated responses or CD81 T cells (Murray et
al., 1998; Rivera-Quinones et al., 1998) predisposes mice
of a normally resistant H-2b haplotype to DA-induced
demyelination. In mice of susceptible SJL background,
genetic deletion of CD41 T cells results in severe demy-
elination, profound neurologic dysfunction, and in-
creased virus load following infection with wild-type virus
(Murray et al., 1998). In contrast, genetic deletion of CD81
T cells does not significantly alter the extent of demyeli-
nation compared to wt-DA infection of SJL mice (Murray
et al., 1998). These experiments implicate a critical role
for CD41 T cells in control of virus replication and pro-
tection from demyelinating disease in mice of suscepti-
ble genotype. These experiments also indicate that in
mice of a susceptible genotype, CD8 T cells play a
minimal role in the control of virus replication.
Even though both CD41 and CD81 T cells play an
T
Pathologic Scores in the Spinal Cords of SJL, SJL CD42/2, and SJL
Virus Mouse strain N**
DA-VP1-99(Ser) SJL 10
DA-VP1-100(Asp) SJL 5
DA-VP1-103(Lys) SJL 6
DAFL3 SJL 15
DA-VP1-99(Ser) SJL CD42/2 4
DA-VP1-100(Asp) SJL CD42/2 4
DA-VP1-103(Lys) SJL CD42/2 5
DAFL3 SJL CD42/2 5
DA-VP1-99(Ser) SJL CD82/2 6
DA-VP1-100(Asp) SJL CD82/2 6
DA-VP1-103(Lys) SJL CD82/2 5
DAFL3 SJL CD82/2 4
* Represents a statistical difference from DAFL3 within an individu
one-way ANOVA on ranks. Pair-wise comparisons were performed usi
** N 5 number of mice.important role in protecting resistant mice from demyeli- mnation and persistence, there are other factors that ap-
pear to have an even greater role in protecting mice from
acute lethal encephalitis. The most important of these is
IFN-a/b. IFN-a/b is important in preventing death and
ontrolling acute TMEV infection. Resistant haplotype
-2b mice deficient in IFN-a/b receptors die of over-
helming encephalitis within a few days of infection
Fiette et al., 1995; Njenga et al., 1997). IFN-a/b has a
irect role in controlling virus spread and also appears to
e a principal mediator of MHC class I expression in the
NS following TMEV infection (Njenga et al., 1997; Van
en Broek et al., 1995).
In the present study, we evaluated the phenotype of
TMEV-induced disease following infection with mutant
viruses DA-VP1-99(Ser), DA-VP1-100(Asp), and DA-VP1-
103(Lys) in susceptible SJL mice with a genetic defi-
ciency of CD41 T cells or CD81 T cells. We also evalu-
ted the neurovirulence of the mutant viruses by infect-
ng mice deficient in IFN-a/b receptors. The results
indicate that the class II-restricted CD41 T cell-mediated
immune response rather than the class I-restricted CD81
T cell response contributes to the nondemyelinating phe-
notype of mutant attenuated DA-VP1-99(Ser) and DA-
VP1-100(Asp) viruses in normally susceptible SJL mice.
RESULTS
Mutant DA viruses induce demyelination in the spinal
cord of SJL CD42/2 mice but not in that of SJL
CD82/2 mice
We showed previously that mutant DA-VP1-99(Ser) and
A-VP1-100(Asp) viruses failed to induce demyelination
n the spinal cord of highly susceptible SJL mice (Lin et
l., 1998). This was confirmed in the present study when
2 Mice 45 Days following Infection with Mutant or DAFL3 Viruses
% Quadrants (mean 6 SEM) positive for abnormality
Gray matter
inflammation
White matter
inflammation Demyelination
0.0 6 0.0 0.2 6 0.2* 0.0 6 0.0*
0.0 6 0.0 0.0 6 0.0* 0.0 6 0.0*
0.0 6 0.0 22.8 6 8.5 17.9 6 8.0
0.2 6 0.2 26.3 6 5.6 24.9 6 5.5
0.0 6 0.0 6.0 6 2.4 21.7 6 7.8*
0.0 6 0.0 7.3 6 3.7 13.6 6 7.1*
1.0 6 0.7 20.1 6 6.3 43.1 6 12.1*
0.4 6 0.4 23.7 6 4.3 71.9 6 7.9
0.0 6 0.0 1.1 6 0.8 0.7 6 0.4
0.0 6 0.0 0.3 6 0.3* 0.0 6 0.0*
0.0 6 0.0 2.5 6 1.8 2.9 6 2.1
0.0 6 0.0 15.2 6 3.9 12.7 6 2.4
in of mice (P , 0.05). Statistical differences were detected using a
n’s method.ABLE 1
CD82/
al stra
ng Dunice infected with DA-VP1-99(Ser) and DA-VP1-100(Asp)
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11CLEARANCE OF MUTANT DA VIRUSES REQUIRES IMMUNE RESPONSEwere examined at 45 days postinfection (d.p.i.) (Table 1,
Fig. 1). The 45-day time point was chosen because this
has been proven to be a reliable time for distinguishing
virus persistence and demyelination in animals of sus-
ceptible versus resistant genotypes (Rodriguez et al.,
1986). In contrast, infection with DA-VP1-103(Lys) and
wild-type DAFL3 resulted in prominent demyelination in
the spinal cord at 45 d.p.i. (Table 1, Fig. 1). Previous
studies have demonstrated that CD41 T cells are not
necessary for TMEV-induced demyelination because se-
vere white matter lesions are observed in the CNS of SJL
CD42/2 mice infected with DAFL3 (Murray et al., 1998). In
the present study, we tested whether the absence of
demyelination in SJL mice following infection with DA-
VP1-99(Ser) and DA-VP1-100(Asp) was due to clearance
by a CD41 or CD81 T cell-mediated immune response.
We found prominent demyelination in SJL CD42/2 mice
infected with each of the mutant viruses (Table 1, Fig. 1),
FIG. 1. Mutant DA and DAFL3 viruses induce chronic demyelination
D, G, J), SJL CD42/2 mice (B, E, H, K), and SJL CD82/2 mice (C, F, I, L) w
(G, H, I), or DA-VP1-103(Lys) (J, K, L) viruses. DAFL3 (A) and DA-VP1-103
whereas DA-VP1-99 (D) and DA-VP-100 (G) did not. DAFL3 (B), DA-VP
demyelination and white matter inflammation in the spinal cords of SJ
of SJL CD82/2 mice infected with DA-VP1-99(Ser) (F) or DA-VP1-100(Asp
with DA-VP1-100(Lys) (L) and DAFL3 (C). Magnification, 3400. Plastic-e
Quantitation of the number of quadrants showing pathology is shownsuggesting that the lack of demyelination observed fol- Tlowing infection with DA-VP1-99(Ser) or DA-VP1-100(Asp)
virus was explained partly by protection from a CD41 T
ell-mediated immune response. In SJL CD42/2 mice,
A-VP1-99(Ser) and DA-VP1-100(Asp) viruses induced
ignificantly less demyelination and white matter inflam-
ation in the spinal cords than infection with mutant
A-VP1-103(Lys) and DAFL3 (P , 0.05) (Table 1, Fig. 1).
nterestingly, minimal or no demyelination was observed
n the spinal cords of SJL CD82/2 mice infected with
mutant DA-VP1-99(Ser), DA-VP1-100(Asp), or DA-VP1-
103(Lys) virus. In contrast, demyelination was observed
in the spinal cords of SJL CD82/2 mice infected with
DAFL3; however, this pathology was reduced compared
to DAFL3 infection of wild-type SJL mice. At present, the
factors contributing to this reduced pathology are un-
known. In general, more demyelination was observed
following DAFL3 or VP1 mutant virus infection in SJL
CD42/2 mice than in SJL CD82/2 or wild-type SJL mice.
hite matter inflammation in the CNS of SJL CD42/2 mice. SJL mice (A,
ected with DAFL3 (A, B, C), DA-VP1-99(Ser) (D, E, F), DA-VP1-100(Asp)
) induced demyelination (black outline) in immunocompetent SJL mice,
r) (E), DA-VP1-100(Asp) (H), and DA-VP1-103(Lys) (K) viruses induced
2/2 mice. In contrast, no demyelination was observed in spinal cords
all demyelinating lesions were observed in SJL CD82/2 mice infected
ed sections were stained with a modified erichrome/cresyl violet stain.
e 1.and w
ere inf
(Lys) (J
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L/J CD4
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12 RODRIGUEZ ET AL.CD41 T cell-mediated immune response plays a critical
ole in protection from demyelination following infection
ith either the wild-type or the VP1 mutant virus. There-
ore, the presence or absence of the CD4-mediated im-
une response determines whether demyelination de-
elops following infection with these mutant viruses.
owever, the severity of pathology may be determined by
dditional factors, such as virus–cell receptor interac-
ions (Lin et al., 1998).
Mutant DA viruses persist in the CNS of susceptible
genotype (SJL) mice deficient in CD41 T cells
To test whether the mutant viruses persist in the spinal
ords of SJL mice deficient in CD41 or CD81 T cells, we
used in situ hybridization with a 35S-labeled VP2 probe to
localize DAFL3 and VP1 mutant viral RNA in mice in-
fected for 45 days (Fig. 2). This allowed us to precisely
relate the extent of demyelination to the level of virus
RNA persistence in the same animals. Virus RNA was
demonstrated in the spinal cord white matter but not in
the gray matter of SJL CD42/2 mice infected with all three
mutant and DAFL3 viruses [virus-positive cells/mm2
were 4.4 6 2.0 (DA-VP1-99-Ser), 1.3 6 0.8 (DA-VP1-100-
Asp), 10.9 6 5.5 (DA-VP1-103-Lys), and 15.0 6 6.5
DAFL3)]. Of interest, virus-positive cells/mm2 in SJL
CD42/2 mice infected with DA-VP1-99(Ser) and DA-VP1-
100(Asp) were fewer in number than those in mice in-
FIG. 2. In situ hybridization was used to detect virus genome in the
(C) DA-VP1-100(Asp), and (D) DA-VP1-103(Lys). Arrows show virus-RNA-
of virus-RNA-positive cells/mm2 of spinal cord. Similar experiments in
A-VP1-99(Ser) or DA-VP1-100(Asp). Only rarely were positive cells ob
ere found following infection with DAFL3.fected with DA-VP1-103(Lys) or DAFL3. However, theresults did not reach statistical significance. No virus-
RNA-positive cells were identified in the spinal cords of
SJL CD82/2 mice infected with DA-VP1-99(Ser) and DA-
VP1-100(Asp). A low level of virus RNA was demon-
strated in the spinal cord of one of three SJL CD82/2 mice
nfected with DA-VP1-103(Lys), which showed small de-
yelinating lesions. In contrast, viral RNA was demon-
trated in all three SJL CD82/2 mice infected with DAFL3.
hese results indicated that the presence of virus ge-
ome in the spinal cord of mice infected with DAFL3 or
utant viruses coincided with the development of demy-
lination. In addition, the severity of demyelination (Table
) correlated almost perfectly (r 5 0.98, P 5 0.02) with
he number of virus-RNA-positive cells in the spinal
ords of SJL CD42/2 mice. Therefore, CD41 T cells, but
not CD81 T cells, play a critical role in the clearance of
utant DA-VP1-99(Ser) and DA-VP1-100(Asp) viruses
rom the CNS of normally susceptible SJL mice.
To confirm this conclusion, we assessed whether de-
etion of CD41 T cells would predispose mice to infec-
ious virus persistence as detected by plaque assay. SJL
nd SJL CD42/2 mice were sacrificed 45 d.p.i., and the
CNS homogenates were prepared for plaque assays to
determine the levels of infectious virus. Infectious DA-
VP1-99(Ser) and DA-VP1-100(Asp) persisted in the CNS
of SJL CD42/2 mice, although the titers were significantly
lower (P , 0.05) than those of mice infected with DAFL3
ords of SJL CD42/2 mice infected with (A) DAFL3, (B) DA-VP1-99(Ser),
cells localized exclusively in the white matter. See text for quantitation
D82/2 mice showed no virus-RNA-positive cells in mice infected with
following infection with DA-VP1-103(Lys). In contrast, cells frequentlyspinal c
positive
SJL C
servedand DA-VP1-103(Lys) viruses (Table 2). In contrast, no
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13CLEARANCE OF MUTANT DA VIRUSES REQUIRES IMMUNE RESPONSEinfectious DA-VP1-99(Ser) or DA-VP1-100(Asp) was de-
tected in the CNS of immunocompetent SJL mice (Table
2). These studies supported the hypothesis that a CD41
T cell immune response contributes to the clearance of
the mutant viruses from the CNS of susceptible SJL mice.
Plaque assays were not done for SJL CD82/2 mice be-
cause the pathologic studies demonstrated no demyeli-
nation or viral RNA by in situ hybridization following
infection with DA-VP1-99(Ser) or DA-VP1-100(Asp).
An impaired humoral response is observed in SJL
CD42/2 mice infected with VP1 mutant viruses
Having established that the CD41 T cell immune re-
sponse contributed to the clearance of DA-VP1-99(Ser)
and DA-VP1-100(Asp) in SJL mice, we assessed by ELISA
the levels of virus-specific antibodies in the sera of SJL
CD42/2 mice compared to those in the sera of immuno-
ompetent SJL and SJL CD82/2 mice. Previous studies
have demonstrated that mice deficient in CD41 cells
maintain the ability to isotype switch from IgM to IgG
(Rahemtulla et al., 1994). However, it is possible for
CD4-deficient mice to have an inefficient humoral re-
sponse, which may explain the ability of VP1 mutant
viruses to persist in the spinal cords of SJL CD42/2 mice.
We first assessed the humoral immune responses in
immunocompetent SJL, SJL CD82/2, and SJL CD42/2 mice
infected with the mutant VP1 viruses versus those in
wild-type DAFL3 mice (Figs. 3A to 3D). In general, higher
titers of virus-specific antibodies were observed follow-
ing infection of immunocompetent SJL mice with DA-VP1-
99(Ser) and DA-VP1-100(Asp) than in those infected with
DA-VP1-103(Lys) and DAFL3. In addition, infection of SJL
or SJL CD82/2 mice with DAFL3 or the mutant VP1 virus
esulted in higher titers of virus-specific antibody than
hose observed in SJL CD42/2 mice. These data suggest
hat a CD41 T cell-mediated immune response was im-
portant in the development of a humoral response
against all viruses and that an inefficient humoral re-
sponse may have contributed to the phenotype observed
in SJL CD42/2 mice following infection with DA-VP1-
9(Ser) and DA-VP1-100(Asp).
T
Virus Titers in the CNS of SJL and SJL CD42
Mouse strain DA-VP1-99(Ser) DA-VP
SJL 0.00 6 0.00** 0.00
SJL CD42/2 2.51 6 0.45* 2.14
Note. Brain and spinal cords were isolated from mice 45 days follow
and sonicated for plaque assay. Virus titers are expressed as mean 6
.7 log10 PFU/g CNS tissue. Student’s t test was used to compare virus
ith DAFL3.
* P , 0.05.
** P , 0.01.It is also possible that VP1 mutations altered the ability if the humoral response to recognize and neutralize the
iruses (Sato et al., 1996). To test this hypothesis, we
onducted cross-neutralization experiments to deter-
ine whether sera isolated from SJL mice infected with
A-VP1-99(Ser), DA-VP1-100(Asp), and DA-VP1-103(Lys)
ere capable of neutralizing infectious DAFL3 (Fig. 3E).
or a positive control, the results were compared to the
era from SJL mice infected with DAFL3. A plaque assay
as performed using sera from DAFL3, DA-VP1-99(Ser)-,
A-VP1-100(Asp)-, and DA-VP1-103(Lys)-infected SJL
ice. The log2 serum dilution required to obtain 50%
eutralization of infectious DAFL3 virus (1000 PFU/ml)
as significantly greater for the sera collected from SJL
ice infected with all viruses than for the sera isolated
rom uninfected SJL mice (P , 0.05). Thus, sera from
SJL mice infected with the VP1 mutant viruses can neu-
tralize wild-type DAFL3.
Virus-specific cytotoxicity is not observed in the CNS
following infection of SJL mice with VP1 mutant
viruses
Previous studies (Lin et al., 1997, 1999) have demon-
strated that virus-specific cytotoxic lymphocytes (CTLs)
play a critical role in virus clearance from the CNS of
resistant H-2b haplotype mice following wild-type DAFL3
infection. In contrast, susceptible SJL mice mount mini-
mal or no virus-specific CTLs directed against the wild-
type DALF3 virus (Lin et al., 1999). Interestingly, a previ-
ous study demonstrated virus-specific CTLs in the CNS
of SJL mice infected with the mutant DAL*21 virus (Lin et
al., 1999). The mutant DAL*21 virus fails to synthesize
the L* protein and does not persist in the CNS of SJL
mice. SJL mice infected with DAL*21 do have Ks-re-
stricted CTLs in the CNS, suggesting that the generation
of a CTL response may be important in the clearance of
this virus (Lin et al., 1999). To further investigate the role
f CTLs in the clearance of VP1 mutant viruses from the
NS of SJL mice, we assessed whether infection with
A-VP1-99(Ser), DA-VP1-100(Asp), or DA-VP1-103(Lys)
ould result in a virus-specific CTL response (Table 3).
he CNS-infiltrating lymphocytes isolated from SJL mice
Infected with DAFL3 or Mutant DA Viruses
Asp) DA-VP1-103(Lys) DAFL3
** 3.14 6 0.89 1.89 6 0.54
* 5.17 6 0.28 5.36 6 0.40
acerebral inoculation with DAFL3 or mutant DA viruses, homogenized,
rd error (log10 PFU/g CNS tissue). The sensitivity of plaque assay was
in each mouse strain infected with mutant viruses with mice infectedABLE 2
/2 Mice
1-100(
6 0.00
6 1.16
ing intr
standa
titersnfected for 7 days with DAFL3 or mutant virus did not
5
D
a
14 RODRIGUEZ ET AL.demonstrate virus-specific cytotoxicity, regardless of
whether the target cells were infected with the wild-type
FIG. 3. Characterization of the humoral response to wt-DA antigen f
(A) DAFL3, (B) DA-VP1-99(Ser), (C) DA-VP1-100(Asp) or (D) DA-VP1-103(L
albumin. Data are represented as the mean optical density (at 405 nm) 6
0% neutralization of infectious DAFL3 was determined for sera collect
A-VP1-103(Lys). Sera collected from uninfected SJL mice were used as
n individual mouse.or mutant virus. In contrast, for positive control, we in-fected SJL mice with the mutant DAL*21 virus and dem-
onstrated a CTL response against DAL*21- or DAFL3-
g intracerebral infection of SJL, SJL CD42/2 and SJL CD82/2 mice with
ses. Sera were diluted 1:200 to 1:51,200 in PBS with 0.2% bovine serum
ard error at each dilution. (E) The log2 serum dilution required to obtain
SJL mice infected with DAFL3, DA-VP1-99(Ser), DA-VP1-100(Asp), and
ative control. Each point on the graph represents serum collected fromollowin
ys) viru
stand
ed from
a neginfected target cells. Thus, SJL mice can mount a virus-
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15CLEARANCE OF MUTANT DA VIRUSES REQUIRES IMMUNE RESPONSEspecific CTL response when infected with DAL*21.
These studies provide further support for the hypothesis
that CD81 T cells are not critical for viral clearance and
the lack of demyelination observed in SJL mice infected
with the VP1 mutant viruses.
The VP1 mutants are neurovirulent, as demonstrated
by infection of IFN-a/b-receptor-deficient mice
It was hypothesized previously that disruption of mu-
tant VP1 virus–receptor interactions in vivo might have
altered the viruses’ neurovirulence. To assess the neu-
rovirulence of the mutant viruses, we infected AB129
mice, which are of the resistant haplotype H-2b but are
deficient in the IFN-a/b receptors. IFN-a/b protect
against lethality during the acute phase following Theiler
virus infection (Fiette et al., 1995; Njenga et al., 1997; Van
den Broek et al., 1995). Infection of AB129 mice with three
mutant VP1 viruses or the wild-type DAFL3 virus resulted
in death from overwhelming encephalitis at 2 to 4 days
postinfection. Abundant virus genome was detected by
in situ hybridization in the brain and spinal cord of all
infected AB129 mice, irrespective of VP1 mutation (data
not shown). The results demonstrate that IFN-a/b is
ritical in protection from overwhelming encephalitis in-
uced by both the mutant and DAFL3 viruses. Thus, the
utant viruses have neurovirulence similar to that of
AFL3 following inoculation of mice deficient in the IFN-
TABLE 3
CNS Virus-Specific Cytotoxicity from Infected SJL/J Mice
Virus used to
infect SJL/J mice
Virus used to
infect target cell
line (PSJLSV)
% Specific lysis
of target cells
(6SEM)
A-VP1-99(Ser) Uninfected 0.0 6 0.0
DAFL3 0.2 6 0.2
DA-VP1-99(Ser) 2.6 6 1.5
A-VP1-100(Asp) Uninfected 0.0 6 0.0
DAFL3 0.0 6 0.0
DA-VP1-100(Asp) 0.0 6 0.0
A-VP1-103(Lys) Uninfected 0.0 6 0.1
DAFL3 0.0 6 0.0
DA-VP1-103(Lys) 5.3 6 0.2
AFL3 Uninfected 0.0 6 0.0
DAFL3 2.0 6 2.0
DA-VP1-99(Ser) 1.8 6 1.8
DA-VP1-100(Asp) 0.0 6 0.0
DA-VP1-103(Lys) 5.1 6 3.6
AL*21 Uninfected 3.3 6 2.8
DAFL3 15.6 6 2.9
DAL*21 19.5 6 8.0
Note. SJL/J mice were infected intracerebrally with the viruses listed
bove. CNS-infiltrating lymphocytes from five mice per experimental
roup were isolated and pooled at 7 days postinfection. PSLSV (Ks, Ds)
were used as target cells at an effector to target ratio of 100 to 1. PSLSV
target cells were left uninfected (negative control) or were infected with
the viruses listed above.a/b receptors. This finding suggests that the mutant DAiruses are not CNS-growth-deficient viruses during
arly infection, arguing against the simple hypothesis
hat these viruses are attenuated because they fail to
ind to the putative TMEV receptors on susceptible neu-
ons or glial cells.
DISCUSSION
We proposed previously that mutations in DA VP1
esidues 99, 100, and 103 disrupt the interaction between
MEV and its receptors on certain CNS cells (Lin et al.,
998), causing a failure of some of the mutant viruses to
nduce demyelination in susceptible SJL/J mice. In this
tudy we investigated how the immune response was
esponsible in part for the inability of these mutant vi-
uses to induce demyelination in susceptible SJL/J mice.
e utilized SJL CD42/2 mice to test definitively whether
lass II-restricted CD41 T cells, which are known to be
ritical in virus clearance and resistance to TMEV-in-
uced demyelination (Murray et al., 1998; Njenga et al.,
996; Rodriguez et al., 1991), are important in the atten-
ation of the VP1 mutants. Although we showed that
A-VP1-99(Ser) and DA-VP1-100(Asp) failed to induce
emyelination in SJL mice, we demonstrated that these
wo viruses (as well as DAFL3) persisted in the CNS of
JL CD42/2 mice and induced demyelination in the spinal
ord. Of interest, minimal or no demyelination and no
irus-RNA-positive cells were observed in the spinal
ord of SJL CD82/2 mice infected with DA-VP1-99(Ser)
and DA-VP1-100(Asp) mutant viruses. Therefore, the ab-
sence of a class II-restricted CD41 T cell response, but
not a class I-restricted CD81 T cell response, interferes
ith clearance of both DAFL3 and mutant VP1 viruses.
his is consistent with a study by Kurtz and colleagues
1995) that demonstrated the importance of the CD41 T
cell-mediated immune response in viral clearance from
SJL mice. The absence of a CD41 T cell-mediated im-
mune response predisposes normally susceptible SJL
mice to enhanced virus persistence and virus-induced
demyelination following infection with the VP1 mutant
viruses. The results from this study also indicate that the
attenuated phenotype observed following the infection of
immunocompetent SJL mice with DA-VP1-99(Ser) or DA-
VP1-100(Asp) cannot be explained by a disruption in
virus–cell receptor interactions per se.
Despite persistent virus replication and subsequent
demyelination in CD41-deficient mice infected with VP1
mutant viruses, some of our data suggest that interfer-
ence between the virus and its putative receptor on
certain CNS cells may also contribute to the phenotype.
Virus titers by plaque assay in the CNS of SJL CD42/2
mice infected with mutant DA-VP1-99(Ser) and DA-VP1-
100(Asp) were lower than those in mice infected with
DAFL3. Thus, mutations in DA VP1 residues 99 and 100
might disrupt the interaction between virus and receptor
on certain CNS cells independent of the immune re-
sponse. A previously described variant of DA virus
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16 RODRIGUEZ ET AL.(Jnaoui and Michiels, 1998) had mutations in the CD loop
of VP1 [aa (amino acid(s)) 100–102] and the EF loop of
VP2 (aa 162, 171, and 173) and was attenuated in neuro-
virulence similar to our mutants following infection of
immunocompetent SJL mice. The VP1 amino acid
changes in this variant and in our mutant viruses are
clustered in a site recognized by neutralizing antibody
(Sato et al., 1996; Wada et al., 1994; Zurbriggen et al.,
991) that lies on the rim of a depression in the virion
urface called the “pit” (Luo et al., 1992). A mutation at the
rim of the pit may interfere with binding of the virus to the
receptor of a particular cell type (possibly oligodendro-
cytes or microglia). It is also possible that the mutations
altered the tropism of DA-VP1-99(Ser) and DA-VP1-
100(Asp), which has the potential to lessen the severity
of demyelination following infection of SJL CD42/2 mice.
However, the fact that DA-VP1-99(Ser) and DA-VP1-
100(Asp) persisted in the spinal cord white matter of SJL
CD42/2 mice and that the percentage of spinal cord
demyelination (for all viruses) correlated almost perfectly
with the number of virus-positive cells/mm2 (within the
pinal cord white matter) is more consistent with the
ypothesis that a reduced ability to interact with a cel-
ular receptor rather than a change in tropism was re-
ponsible for the observed phenotype. This hypothesis is
lso supported by a previous study that demonstrated
maller plaque sizes on L-2 cell monolayers infected
ith DA-VP1-99(Ser) or DA-VP1-100(Asp) (Lin et al., 1998)
han on DAFL3 controls. In any case, future experiments
ill be designed to definitively prove this hypothesis.
To further assess the neurovirulence of mutant VP1
iruses, we infected mice deficient in the IFN-a/b recep-
ors. IFN-a/b rises rapidly following virus infection, in-
duces a generalized antiviral state in neighboring unin-
fected cells, and activates macrophages/NK cells (Sen
and Lengyel, 1992). IFN-a/b also upregulates MHC class
expression in the CNS of mice following infection with
t-DA virus (Njenga et al., 1997), potentially enhancing
ytotoxic lymphocyte function in resistant mice. In this
tudy we demonstrated that the mutant VP1 viruses are
eurovirulent and that IFN-a/b plays a critical role in
efense against the lethality of both mutant DA and
AFL3 viruses during acute infection. All the viruses had
similar acute lethality following inoculation of AB129
ice deficient in IFN-a/b receptors. The mutant DA-VP1-
99(Ser) and DA-VP1-100(Asp) viruses did not manifest
their distinctive mutant phenotypes in IFN-a/b receptor
knockout mice and behaved similarly to DAFL3 and DA-
VP1-103(Lys). Although the two mutant viruses may have
decreased virus growth in the CNS compared to DAFL3
(Lin et al., 1998), they are lethal to mice in the face of
severe weakening of the immune response that is critical
for resistance.
Because a reduction in neurovirulence alone was not
responsible for viral clearance and the absence of de-
myelination observed following infection of immunocom-
petent SJL mice with DA-VP1-99(Ser) and DA-VP1-100(Asp), we further examined the role of the immune
response. The demyelinating phenotype observed fol-
lowing infection of SJL CD42/2 suggested that a CD41 T
ell-mediated immune response was involved. To com-
letely rule out a role for CD81 T cells in contributing to
the attenuated phenotype of the mutant viruses, we as-
sessed virus-specific cytotoxicity in infiltrating lympho-
cytes from the CNS. This was important because our
previous studies with mutant virus DAL*21 showed that
it was likely that the presence of virus-specific CTLs
accounted for the absence of virus persistence and de-
myelination following infection of SJL mice with the mu-
tant DAL*21 (Lin et al., 1999). Infection of SJL mice with
the DAL*21 virus, which does not synthesize the L*
protein, results in the generation of Ks-restricted CTLs in
the CNS of SJL mice that appear to be critical for early
virus clearance. In contrast to DAL*21, infection of VP1
mutant viruses did not result in the generation of virus-
specific CTLs in the CNS of SJL mice. This fits well with
the observation that infection of SJL CD82/2 mice with
VP1 mutant viruses did not result in virus persistence or
demyelination.
The potential mechanisms by which CD41 T cells
contribute to viral clearance following TMEV infection
are multiple and include the optimal generation and
maintenance of DA-specific CTLs in the CNS, the secre-
tion of lymphokines that activate either macrophages or
NK cell function, the production of virus-specific antibod-
ies, and the direct control of virus infection or amplifica-
tion (Koszinowski et al., 1991). To address the role of the
umoral response, we assessed virus-specific antibody
iters in SJL, SJL CD82/2, and SJL CD42/2 mice. Com-
pared to SJL and SJL CD82/2, virus-specific antibody
iters were reduced in all SJL CD42/2 mice following
infection with both wild-type and mutant viruses. In ad-
dition, sera isolated from mice infected with the mutant
viruses had reduced ability to neutralize wild-type DAFL3
compared to the sera isolated from mice infected with
DAFL3, suggesting that antibodies recognizing the mu-
tant viruses with single point mutations were different
from those that recognized the wild-type virus. This may
have resulted from the presence of mutations in a major
TMEV neutralization site (Sato et al., 1996). Thus, an
impaired humoral response in SJL CD42/2 mice may
partly explain the demyelinating phenotype observed fol-
lowing infection with DA-VP1-99(Ser) and DA-VP1-
100(Asp).
In summary, these results demonstrate the complex
mechanisms of the attenuated phenotype and lack of
virus persistence/demyelination following infection of
highly susceptible SJL mice with VP1 mutant DA viruses.
We propose that the DA-VP1-99(Ser) and DA-VP1-
100(Asp) viruses may have reduced ability to interact
with cellular receptors on CNS cells as a consequence
of the VP1 point mutations. This results in a decreased
efficiency of infection in immunocompetent SJL mice.
Clearance of the mutant viruses involves an intact class
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17CLEARANCE OF MUTANT DA VIRUSES REQUIRES IMMUNE RESPONSEII-restricted immune CD41 T cell. In the absence of class
I-restricted CD41 T cells, an impaired humoral response
may provide these mutant viruses with the opportunity to
establish viral persistence in the spinal cord white matter
and to induce demyelination. In addition, reduced lym-
phokine-induced activation of antigen-presenting cells
and decreased intracellular antiviral defenses may have
also contributed to a broader immunodeficiency that
enabled the mutant viruses to persist. Therefore, the
ultimate outcome of infection with these VP1 mutant
viruses depends on both the host immune defense re-
sponse and the virulence of the virus.
MATERIALS AND METHODS
TMEV viruses
DAFL3 virus was prepared from a wild-type DA full-
length infectious cDNA clone (pDAFL3). Mutant DA-VP1-
99(Ser), DA-VP1-100(Asp), and DA-VP1-103(Lys) viruses
were generated by site-directed mutagenesis of DAFL3,
as previously described (Lin et al., 1998). DAFL3 and the
three mutant DA viruses were propagated in BHK-21
cells and used in all the experiments.
Cells
L-2 and BHK-21 cells were cultured in RPMI 1640
(BioWhittaker, Walkersville, MD) with 5% fetal calf serum
(GibcoBRL, Grand Island, NY) and used for plaque as-
says to titrate viruses and for preparation of virus stocks.
Animals
Four- to eight-week-old female SJL/J (H-2s) and B6
(H-2b) mice were purchased from Jackson Laboratories
Bar Harbor, ME). Four- to eight-week-old female SJL
D42/2 (H-2s), SJL CD82/2 (H-2s), and AB129 (H-2b) mice
eficient in IFN-a/b receptors were bred in the Rodri-
uez laboratory at the Mayo Clinic. Animals were intra-
erebrally injected with 2 3 105 PFU of viruses in a 10 ml
olume. Care and handling of mice conformed to the
uidelines of both the National Institutes of Health and
he Mayo Clinic Animal Care and Use Committee.
athologic analyses
Mice were anaesthetized with pentobarbital and per-
used by intracardiac puncture with Trump’s fixative
phosphate-buffered 4% paraformaldehyde and 1% glu-
araldehyde, pH 7.2). Spinal cords were removed, sec-
ioned coronally and serially into 15 to 20 blocks, osmi-
ated, and embedded in 2-hydroxyethyl methacrylate
JB-4 system from Polysciences). Sections (2-mm-thick)
ere stained with a modified erichrome method with
resyl violet counterstain (Pierce and Rodriguez, 1989) to
etect demyelination and inflammation. Detailed mor-
hologic analysis was performed by examining each
uadrant from 15 to 20 spinal cord coronal sections from
ach mouse for the presence or absence of demyelina- ption, white matter inflammation, and gray matter inflam-
mation (Rodriguez et al., 1983). The presence or absence
of the pathologic abnormality was determined in every
spinal cord quadrant. The total score was expressed as
the percentage of spinal cord quadrants with the specific
abnormality such that a maximum score of 100 repre-
sented the presence of disease in every quadrant of
every spinal cord section examined. Statistical differ-
ences between pathologic scores were assessed using
a one-way ANOVA on ranks. Pair-wise comparisons
were made using the Dunn method (P , 0.05).
irus plaque assay
Infectious virus titers in the CNS of mice were deter-
ined by a plaque assay. Forty-five days postinfection,
rains and spinal cords were removed aseptically. CNS
omogenates (10%) were prepared in RPMI 1640, soni-
ated twice for 3 min each, clarified by centrifugation,
nd stored at 270°C. Virus titers of CNS homogenates
ere determined by plaque assay on monolayers of L-2
ells, as described previously (Patick et al., 1990). The
esults were expressed as mean (log10 PFU/g CNS tis-
ue) 6 SEM calculated from two to five mice in each
roup. Statistical differences between groups were de-
ected using an unpaired Student’s t test (P , 0.05).
n situ hybridization for viral RNA
In situ hybridization was used to detect virus genome
n the CNS of mice. Sections of paraffin-embedded spi-
al cord were hybridized overnight with a 35S-labeled
probe complementary to the coding region of VP2. Slides
were exposed to autoradiography for 48 h after extensive
washing, as described previously (Patick et al., 1990).
Slides were counterstained with hematoxylin. Data were
expressed as the number of virus-RNA-positive cells/
mm2. To calculate this number, we manually counted the
irus-RNA-positive cells and divided this by the area of
he spinal cord sampled. The area sampled was calcu-
ated using a Zeiss interactive digital analysis system
ZIDAS) and a camera lucida attached to a Zeiss pho-
omicroscope. We analyzed from 10.31 mm2 to 25.79 mm2
(mean 5 18.93 mm2) of spinal cord from three to four
ice per group. Statistical differences were assessed
sing a one-way ANOVA. Pair-wise comparisons were
ade using the Student–Newman–Keuls method (P ,
.05). The correlation coefficient between spinal cord
emyelination and virus-RNA-positive cells/mm2 in SJL
D42/2 was calculated using a Pearson product moment
orrelation (P , 0.05).
irus-specific antibody ELISA’s
The presence of anti-DA antibodies (IgG 1 IgM) in the
era of infected mice was determined by an enzyme-
inked immunosorbent assay as described previously
Njenga et al., 1996). In brief, polystyrene microtiter
lates were coated with purified wild-type DAFL3. Sera
iw
F
J
K
L
L
L
L
L
M
N
N
R
R
18 RODRIGUEZ ET AL.from individual mice (four mice per group) were serially
diluted and incubated at room temperature. Biotinylated
goat anti-mouse IgG and IgM were used as the second-
ary antibody. Amplification was performed using alkaline
phosphatase conjugated to streptavidin. Detection was
performed using p-nitrophenyl phosphatase as a sub-
strate. The antibody level was expressed as an optical
density reading of 405 nm.
Virus neutralization assay
Samples of TMEV were diluted to contain 50 PFU/0.2
ml and were mixed with an equal volume of two-fold
dilutions of heat-inactivated (45 min, 56°C) serum from
infected mice or noninfected mice. Four mice were
tested per group. After incubation at 25°C for one h,
virus–serum mixtures were assayed for infectious virus
by plaque assay. Neutralization titers were expressed as
the log2 dilution of serum that resulted in a 50% reduction
n virus titer. Statistical differences between log2 dilu-
tions of serum were detected using a one-way ANOVA.
Pair-wise comparisons were made using the Student–
Newman–Keuls method (P , 0.05).
Virus-specific cytotoxicity assay
SJL/J mice were intracerebrally inoculated with 2 3 105
PFU of mutant viruses, DAFL3, or DAL*21 virus in a 10-ml
volume. Five animals were pooled per experimental
group. At 7 d.p.i., CNS-infiltrating lymphocytes were iso-
lated by Percoll gradient as described previously (Lin et
al., 1997, 1999) to serve as effectors for the cytotoxicity
assay. Uninfected and virus-infected PSJLSV (Ks, Ds) cells
ere labeled with 51Cr (200 mCi/106 cells) for 1 h, washed
three times with RPMI 1640, and used as targets for a
cytotoxicity assay. The cytotoxicity assay was performed
as described previously (Lin et al., 1997, 1999). Mean
radioactivity values were calculated from triplicate wells,
and results were expressed as the percentage specific
lysis according to the formula [(experimental counts 2
spontaneous counts)/(maximum counts 2 spontaneous
counts)] 3 100%. Standard error of the mean was calcu-
lated from the pooled lymphocyte samples in triplicate
wells.
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